Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Dec;22(4):276-7.
doi: 10.3341/kjo.2008.22.4.276.

Transforming growth factor-beta does not induce endothelin-1 secretion in primary cultured human tenon's fibroblasts

Samin Hong, Chan Yun Kim, Jong Bok Lee, Iizuka Yoko, Gong Je Seong

Transforming growth factor-beta does not induce endothelin-1 secretion in primary cultured human tenon's fibroblasts

Samin Hong et al. Korean J Ophthalmol. 2008 Dec.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Representative Western immunoblots. (A) collagen type I, (B) fibronectin, (C) endothelin-1, and (D) beta-actin.
Fig. 2
Fig. 2
Intensity of bands in Western immunoblots. Intensity of each band was calculated as compared with that of 0 hr time point.
See this image and copyright information in PMC

References

    1. Kay EP, Lee HK, Park KS, Lee SC. Indirect mitogenic effect of transforming growth factor-beta on cell proliferation of subconjunctival fibroblasts. Invest Ophthalmol Vis Sci. 1998;39:481–486. - PubMed
    1. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 2003;48:314–346. - PubMed
    1. Mead AL, Wong TT, Cordeiro MF, et al. Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci. 2003;44:3394–3401. - PubMed
    1. Nakamura H, Siddiqui SS, Shen X, et al. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Mol Vis. 2004;10:703–711. - PubMed
    1. CAT-152 0102 Trabeculectomy Study Group. Khaw P, Grehn F, et al. A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology. 2007;114:1822–1830. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources